APCINTEX LIMITED - ALTRINCHAM
| Company Profile | Company Filings |
Overview
APCINTEX LIMITED is a Private Limited Company from ALTRINCHAM UNITED KINGDOM and has the status: Active.
APCINTEX LIMITED was incorporated 9 years ago on 16/06/2014 and has the registered number: 09088717. The accounts status is SMALL and accounts are next due on 30/09/2024.
APCINTEX LIMITED was incorporated 9 years ago on 16/06/2014 and has the registered number: 09088717. The accounts status is SMALL and accounts are next due on 30/09/2024.
APCINTEX LIMITED - ALTRINCHAM
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
| Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
|---|---|---|
| 31 / 12 | 31/12/2022 | 30/09/2024 |
Registered Office
3RD FLOOR
ALTRINCHAM
CHESHIRE
WA14 2DT
UNITED KINGDOM
This Company Originates in : United Kingdom
Previous trading names include:
SERPIN HAEMOSTATICS LIMITED (until 02/04/2016)
SERPIN HAEMOSTATICS LIMITED (until 02/04/2016)
Confirmation Statements
| Last Statement | Next Statement Due |
|---|---|
| 07/02/2023 | 21/02/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
| Name | Born | Nationality | Role | Appointed | Status |
|---|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2021-11-30 | CURRENT | ||
| PATRICK YUE | Apr 1974 | American | Director | 2023-08-17 | CURRENT |
| MR IQBAL HUSSAIN | Feb 1981 | British | Director | 2021-01-29 | CURRENT |
| RICHARD MENZIUSO | Apr 1975 | American | Director | 2022-11-01 | CURRENT |
| DAVID MIN CHAO | May 1967 | American | Director | 2021-11-30 | CURRENT |
| IP2IPO SERVICES LIMITED | Corporate Director | 2018-04-05 UNTIL 2021-01-29 | RESIGNED | ||
| DR DANIEL BACH GONZALEZ | Dec 1974 | Spanish | Director | 2016-12-07 UNTIL 2018-04-05 | RESIGNED |
| THE CAMBRIDGE PARTNERSHIP LIMITED | Corporate Secretary | 2014-06-16 UNTIL 2021-11-01 | RESIGNED | ||
| PROFESSOR JAMES ANDREW HUNTINGTON | Dec 1964 | British | Director | 2016-12-07 UNTIL 2021-01-29 | RESIGNED |
| MS MARELLA THORELL | Mar 1967 | American | Director | 2021-01-29 UNTIL 2022-07-31 | RESIGNED |
| DR KEVIN STUART JOHNSON | Aug 1960 | British | Director | 2014-06-16 UNTIL 2021-01-29 | RESIGNED |
| DR SAURABH SAHA | Nov 1976 | American | Director | 2021-01-29 UNTIL 2021-11-30 | RESIGNED |
| DR DAVID JOHN GRAINGER | Oct 1966 | British | Director | 2014-06-16 UNTIL 2016-12-07 | RESIGNED |
| DR TREVOR PATRICK BAGLIN | Jun 1958 | British | Director | 2016-12-07 UNTIL 2021-01-29 | RESIGNED |
Persons with Significant Control
| Name | Active from | Born | Address | Level of control |
|---|---|---|---|---|
| Centessa Pharmaceuticals (Uk) Limited | 2022-12-20 | Altrincham Cheshire |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
|
| Centessa Pharmaceuticals Plc | 2021-01-29 - 2022-12-20 | Altrincham Cheshire |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
|
| Touchstone Innovations Businesses Llp | 2016-12-07 - 2021-01-29 | London |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Free Reports Available
| Report | Date Filed | Date of Report | Assets |
|---|---|---|---|
| ApcinteX Limited - Accounts to registrar (filleted) - small 18.2 | 2021-10-02 | 31-12-2020 | £11,048,377 Cash £11,679,933 equity |
| ApcinteX Limited - Accounts to registrar (filleted) - small 18.2 | 2020-03-27 | 30-06-2019 | £4,721,568 Cash £6,482,702 equity |
| ApcinteX Limited - Accounts to registrar (filleted) - small 18.2 | 2019-03-28 | 30-06-2018 | £5,925,654 Cash £6,838,101 equity |
| ApcinteX Limited - Accounts to registrar (filleted) - small 17.3 | 2018-03-30 | 30-06-2017 | £4,707,029 Cash £4,725,064 equity |
| ApcinteX Limited - Abbreviated accounts 16.3 | 2017-03-31 | 30-06-2016 | £131,856 Cash £-507,528 equity |
| Serpin Haemostatics Limited - Limited company - abbreviated - 11.9 | 2016-03-17 | 30-06-2015 | £149,754 Cash £-292,800 equity |